{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:36:44Z","timestamp":1792708604346,"version":"4.5.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.survophthal.2006.10.017","type":"journal-article","created":{"date-parts":[[2007,1,19]],"date-time":"2007-01-19T07:18:45Z","timestamp":1169191125000},"page":"S3-S19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"S","title":["Ocular Neovascularization: Basic Mechanisms and Therapeutic Advances"],"prefix":"10.1016","volume":"52","author":[{"given":"Michael","family":"Dorrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Uusitalo-Jarvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2006.10.017_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1097-2765(04)00102-9","article-title":"Endostatin's antiangiogenic signaling network","volume":"13","author":"Abdollahi","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00006982-200502000-00001","article-title":"The role of vascular endothelial growth factor in ocular health and disease","volume":"25","author":"Adamis","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2006.10.017_bib3","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000268033","article-title":"Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies","volume":"29","author":"Aiello","year":"1997","journal-title":"Ophthalmic Res"},{"issue":"Suppl 2","key":"10.1016\/j.survophthal.2006.10.017_bib4","doi-asserted-by":"crossref","first-page":"S263","DOI":"10.1016\/S0039-6257(02)00391-0","article-title":"The potential role of PKC beta in diabetic retinopathy and macular edema","volume":"47","author":"Aiello","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1167\/iovs.05-0757","article-title":"Inhibition of PKC beta by oral administration of ruboxistaurin is well tolerated and ameliorates diabetes-induced retinal hemodynamic abnormalities in patients","volume":"47","author":"Aiello","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib7","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","article-title":"Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins","volume":"92","author":"Aiello","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib8","doi-asserted-by":"crossref","first-page":"C136","DOI":"10.1152\/ajpcell.1999.276.1.C136","article-title":"Squalamine, a novel cationic steroid, specifically inhibits the brush-border Na+\/H+ exchanger isoform NHE3","volume":"276","author":"Akhter","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/104454904323145254","article-title":"Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells","volume":"23","author":"Albig","year":"2004","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib10","first-page":"2520","article-title":"Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium","volume":"31","author":"Alexander","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","article-title":"Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity","volume":"1","author":"Alon","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib12","first-page":"2683","article-title":"Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy","volume":"40","author":"Andrews","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib13","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1073\/pnas.86.12.4544","article-title":"An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes","volume":"86","author":"Antonelli-Orlidge","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib14","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1167\/iovs.04-0172","article-title":"Stimulation of neovascularization by the anti-angiogenic factor PEDF","volume":"45","author":"Apte","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0945-053X(03)00005-2","article-title":"Thrombospondins 1 and 2 function as inhibitors of angiogenesis","volume":"22","author":"Armstrong","year":"2003","journal-title":"Matrix Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib17","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","article-title":"Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders","volume":"1","author":"Autiero","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.survophthal.2006.10.017_bib18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0002-9440(10)64253-8","article-title":"Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas","volume":"161","author":"Baker","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib20","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1167\/iovs.05-1096","article-title":"T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification","volume":"47","author":"Banin","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib21","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.preteyeres.2004.05.002","article-title":"Neuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potential","volume":"23","author":"Barnstable","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib22","first-page":"853","article-title":"TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: possible role of glial cells in endothelial barrier function","volume":"42","author":"Behzadian","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib23","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nm1037","article-title":"Regulation of angiogenesis by tissue factor cytoplasmic domain signaling","volume":"10","author":"Belting","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib24","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/320584a0","article-title":"Cachectin and tumour necrosis factor as two sides of the same biological coin","volume":"320","author":"Beutler","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2006.10.017_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/13679","article-title":"Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment","volume":"17","author":"Birchler","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1083\/jcb.200401150","article-title":"Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin","volume":"166","author":"Bix","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/ja003579+","article-title":"Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin alpha(V)beta(3)","volume":"123","author":"Boger","year":"2001","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.survophthal.2006.10.017_bib28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","article-title":"The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat","year":"2005","journal-title":"Neuro-oncol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib29","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0022-3468(05)80308-2","article-title":"The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis","volume":"28","author":"Brem","year":"1993","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.survophthal.2006.10.017_bib30","first-page":"3466","article-title":"Immunolocalization of integrins in the human retina","volume":"35","author":"Brem","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib31","first-page":"198","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2","volume":"119","author":"Bressler","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/archopht.123.9.1283","article-title":"Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7","volume":"123","author":"Bressler","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0167-4838(99)00279-4","article-title":"Tissue inhibitors of metalloproteinases: evolution, structure and function","volume":"1477","author":"Brew","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.survophthal.2006.10.017_bib34","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib35","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"Brooks","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0092-8674(00)80931-9","article-title":"Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity","volume":"92","author":"Brooks","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib37","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0092-8674(00)81235-0","article-title":"Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3","volume":"85","author":"Brooks","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib38","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1582-4934.2005.tb00379.x","article-title":"Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF)","volume":"9","author":"Byrne","year":"2005","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1167\/iovs.03-0955","article-title":"Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412","volume":"45","author":"Campochiaro","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.yexcr.2005.09.019","article-title":"Endothelial cadherins and tumor angiogenesis","volume":"312","author":"Cavallaro","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib41","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1073\/pnas.84.18.6471","article-title":"Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor","volume":"84","author":"Cheresh","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.bbrc.2005.04.174","article-title":"Pleiotrophin induces formation of functional neovasculature in vivo","volume":"332","author":"Christman","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.survophthal.2006.10.017_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/14796694.1.2.221","article-title":"Epidermal growth factor receptor inhibitors in cancer treatment","volume":"1","author":"Ciardiello","year":"2005","journal-title":"Future Oncol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib44","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00006982-200312000-00011","article-title":"Squalamine lactate reduces choroidal neovascularization in a laser-injury model in the rat","volume":"23","author":"Ciulla","year":"2003","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2006.10.017_bib45","first-page":"2158","article-title":"Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate","volume":"40","author":"Clark","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/glia.20361","article-title":"Epidermal growth factor receptor expression regulates proliferation in the postnatal rat retina","volume":"54","author":"Close","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.survophthal.2006.10.017_bib47","first-page":"2520","article-title":"Anti-angiogenic cues from vascular basement membrane collagen","volume":"60","author":"Colorado","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/joe.0.1730219","article-title":"Roles of prolactin and related members of the prolactin\/growth hormone\/placental lactogen family in angiogenesis","volume":"173","author":"Corbacho","year":"2002","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib49","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI1555","article-title":"Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis","volume":"101","author":"Coughlin","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2006.10.017_bib50","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1126\/science.2416056","article-title":"A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment","volume":"230","author":"Crum","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib51","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.exer.2004.01.010","article-title":"Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor","volume":"78","author":"Csaky","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib52","first-page":"3974","article-title":"Mechanisms of retinal and choroidal neovascularization","volume":"35","author":"D'Amore","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mrd.1080270104","article-title":"Transforming growth factor-alpha","volume":"27","author":"Derynck","year":"1990","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.survophthal.2006.10.017_bib55","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2003-09-3012","article-title":"Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina","volume":"103","author":"Dorrell","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2006.10.017_bib56","first-page":"3325","article-title":"Angiostatin inhibits pathological but not physiological retinal angiogenesis","volume":"42","author":"Drixler","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib57","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1023\/A:1007657109012","article-title":"Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys","volume":"17","author":"Drolet","year":"2000","journal-title":"Pharm Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1023\/A:1006436624862","article-title":"Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs","volume":"50","author":"Dunn","year":"2000","journal-title":"J Neurooncol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/01676830590912562","article-title":"Infliximab: a novel treatment for sight-threatening thyroid associated ophthalmopathy","volume":"24","author":"Durrani","year":"2005","journal-title":"Orbit"},{"key":"10.1016\/j.survophthal.2006.10.017_bib60","first-page":"696","article-title":"The integrin superfamily and the eye","volume":"37","author":"Elner","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib61","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1167\/iovs.03-0371","article-title":"Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization","volume":"44","author":"Espinosa-Heidmann","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib62","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.survophthal.2006.10.017_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000088479","article-title":"VEGF as a therapeutic target in cancer","volume":"69","author":"Ferrara","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib64","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/endo-129-2-896","article-title":"The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells","volume":"129","author":"Ferrara","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/edrv-13-1-18","article-title":"Molecular and biological properties of the vascular endothelial growth factor family of proteins","volume":"13","author":"Ferrara","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1016\/j.survophthal.2006.10.017_bib66","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1021\/bi00341a030","article-title":"Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells","volume":"24","author":"Fett","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.survophthal.2006.10.017_bib67","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","article-title":"Angiogenesis","volume":"267","author":"Folkman","year":"1992","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2006.10.017_bib68","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in diabetes","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.survophthal.2006.10.017_bib69","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","article-title":"Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases","volume":"93","author":"Friedlander","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1042\/BJ20051578","article-title":"Intracellular signalling pathways activated by leptin","volume":"393","author":"Fr\u00fchbeck","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.survophthal.2006.10.017_bib71","first-page":"3576","article-title":"Elevation of vitreous leptin in diabetic retinopathy and retinal detachment","volume":"41","author":"Gariano","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib72","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1083\/jcb.77.3.774","article-title":"Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin","volume":"77","author":"Gospodarowicz","year":"1978","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-4615-0169-5_5","article-title":"The contribution of adult hematopoietic stem cells to retinal neovascularization","volume":"522","author":"Grant","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib74","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2337\/diacare.23.4.504","article-title":"The efficacy of octreotide in the therapy of severe nonproliferative and early proliferative diabetic retinopathy: a randomized controlled study","volume":"23","author":"Grant","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.survophthal.2006.10.017_bib75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcp.10128","article-title":"Angiopoietin-2 plays an important role in retinal angiogenesis","volume":"192","author":"Hackett","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib76","first-page":"6884","article-title":"Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors","volume":"62","author":"Hagedorn","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib77","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm0596-529","article-title":"Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization","volume":"2","author":"Hammes","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib78","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archopht.1991.01080070117048","article-title":"Altered distribution of basic fibroblast growth factor in diabetic retinopathy","volume":"109","author":"Hanneken","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib79","doi-asserted-by":"crossref","first-page":"642.e1","DOI":"10.1016\/j.ophtha.2005.10.052","article-title":"Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I\/II multicenter, controlled, multidose study","volume":"113","author":"Heier","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib80","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/0-306-46837-9_18","article-title":"Vasostatins. Vascular targets","volume":"482","author":"Helle","year":"2000","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2005.05.001","article-title":"Thrombospondin 1, thrombospondin 2 and the eye","volume":"25","author":"Hiscott","year":"2005","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib82","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0092-8674(92)90115-S","article-title":"Integrins: versatility, modulation, and signaling in cell adhesion","volume":"69","author":"Hynes","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib84","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nm877","article-title":"Leukocytes mediate retinal vascular remodeling during development and vaso-obliteration in disease","volume":"9","author":"Ishida","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/338557a0","article-title":"Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor","volume":"338","author":"Ishikawa","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2006.10.017_bib86","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/01.cad.0000176502.40810.b0","article-title":"Taurolidine\u2014a new drug with anti-tumor and anti-angiogenic effects","volume":"16","author":"Jacobi","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.survophthal.2006.10.017_bib87","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)64869-9","article-title":"Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo","volume":"160","author":"Joussen","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib88","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1101\/sqb.2002.67.255","article-title":"Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis","volume":"67","author":"Kalluri","year":"2002","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib89","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","article-title":"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth","volume":"275","author":"Kamphaus","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib90","doi-asserted-by":"crossref","first-page":"10705","DOI":"10.1073\/pnas.90.22.10705","article-title":"Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor","volume":"90","author":"Kendall","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib91","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M003668200","article-title":"Regulation of integrin alpha vbeta 3-mediated endothelial cell migration and angiogenesis by integrin alpha5beta1 and protein kinase A","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib92","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1076\/ceyr.16.4.396.10685","article-title":"Expression of FGF5 in choroidal neovascular membranes associated with ARMD","volume":"16","author":"Kitaoka","year":"1997","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib93","doi-asserted-by":"crossref","first-page":"30469","DOI":"10.1074\/jbc.M403026200","article-title":"Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1). Implications for macular degenerations","volume":"279","author":"Klenotic","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib94","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1126\/science.1281554","article-title":"Interleukin-8 as a macrophage-derived mediator of angiogenesis","volume":"258","author":"Koch","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1083\/jcb.140.2.419","article-title":"Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis","volume":"140","author":"Kyriakides","year":"1998","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib96","first-page":"2401","article-title":"Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin","volume":"42","author":"Lai","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib97","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.gt.3301695","article-title":"Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy","volume":"9","author":"Lai","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.survophthal.2006.10.017_bib98","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1083\/jcb.121.1.163","article-title":"Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms","volume":"121","author":"Leavesley","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib99","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independent endothelial protection of liver: role of VEGFR-1","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib100","first-page":"563","article-title":"Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model","volume":"75","author":"Luna","year":"1996","journal-title":"Lab Invest"},{"key":"10.1016\/j.survophthal.2006.10.017_bib101","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1535-6108(03)00077-1","article-title":"2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF","volume":"3","author":"Mabjeesh","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib102","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1065298","article-title":"Tumstatin, an endothelial cell-specific inhibitor of protein synthesis","volume":"295","author":"Maeshima","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.1688470","article-title":"Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides","volume":"247","author":"Maione","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib104","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib105","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (Avastin)","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2006.10.017_bib106","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.1063889","article-title":"Liver organogenesis promoted by endothelial cells prior to vascular function","volume":"294","author":"Matsumoto","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib107","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00006982-200603000-00003","article-title":"Electrophysiologic findings after intravitreal bevacizumab (Avastin) treatment","volume":"26","author":"Maturi","year":"2006","journal-title":"Retina"},{"issue":"Pt 5","key":"10.1016\/j.survophthal.2006.10.017_bib108","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/eye.1991.99","article-title":"Effect of a long-acting somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: a pilot study","volume":"5","author":"McCombe","year":"1991","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.017_bib109","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJM199004053221406","article-title":"Diabetic retinopathy. A synthesis of perspectives","volume":"322","author":"Merimee","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib110","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib111","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model","volume":"145","author":"Miller","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib112","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1074\/jbc.M210445200","article-title":"Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan","volume":"278","author":"Mongiat","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib113","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1073\/pnas.90.4.1354","article-title":"Squalamine: an aminosterol antibiotic from the shark","volume":"90","author":"Moore","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib114","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/019262339902700104","article-title":"Efficacy and concentration-response of murine anti-VEGF monoclonal antibody in tumor-bearing mice and extrapolation to humans","volume":"27","author":"Mordenti","year":"1999","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib115","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.96.6.2645","article-title":"Troponin I is present in human cartilage and inhibits angiogenesis","volume":"96","author":"Moses","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib116","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1517\/14712598.5.7.997","article-title":"Bevacizumab in the treatment of colorectal cancer","volume":"5","author":"Mulcahy","year":"2005","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.survophthal.2006.10.017_bib117","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.gt.3302230","article-title":"Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier","volume":"11","author":"Nambu","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.survophthal.2006.10.017_bib118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.20292","article-title":"Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization","volume":"204","author":"Nambu","year":"2005","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib119","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd1955","article-title":"Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease","volume":"5","author":"Ng","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.survophthal.2006.10.017_bib120","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjo.2005.066431","article-title":"Bevacizumab suppresses choroidal neovascularisation caused by pathological myopia","volume":"89","author":"Nguyen","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib121","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1167\/iovs.02-0493","article-title":"Inhibitory effects of antithrombin III on interactions between blood cells and endothelial cells during retinal ischemia-reperfusion injury","volume":"44","author":"Nishijima","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib122","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib123","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib124","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","article-title":"Antiangiogenic activity of the cleaved conformation of the serpin antithrombin","volume":"285","author":"O'Reilly","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI200421686","article-title":"Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells","volume":"114","author":"Otani","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2006.10.017_bib126","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nm744","article-title":"Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis","volume":"8","author":"Otani","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib127","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1073\/pnas.012601899","article-title":"A fragment of human TrpRS as a potent antagonist of ocular angiogenesis","volume":"99","author":"Otani","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib128","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000267929","article-title":"Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy","volume":"28","author":"Ozaki","year":"1996","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/112067210501500309","article-title":"Protective effects of antithrombin III on retinal ischemia\/reperfusion injury in rats: a histopathologic study","volume":"15","author":"Ozden","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib130","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1167\/iovs.03-1001","article-title":"Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice","volume":"45","author":"Pan","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib131","doi-asserted-by":"crossref","first-page":"37632","DOI":"10.1074\/jbc.M307339200","article-title":"Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells","volume":"278","author":"Panka","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib132","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1167\/iovs.02-0804","article-title":"Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity","volume":"44","author":"Penn","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib133","first-page":"283","article-title":"The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity","volume":"42","author":"Penn","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib134","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","article-title":"Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity","volume":"8","author":"Pepper","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.survophthal.2006.10.017_bib135","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1182\/blood.V94.7.2461.419a26_2461_2468","article-title":"Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth","volume":"94","author":"Pike","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.survophthal.2006.10.017_bib136","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI0213776","article-title":"Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF","volume":"109","author":"Poulaki","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.survophthal.2006.10.017_bib137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","article-title":"Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis","volume":"16","author":"Presta","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.survophthal.2006.10.017_bib138","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes","volume":"42","author":"Qaum","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib139","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/labinvest.3700115","article-title":"Abnormal retinal vascular development in IL-18 knockout mice","volume":"84","author":"Qiao","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.survophthal.2006.10.017_bib140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s11892-005-0020-5","article-title":"Endothelial effects of leptin: implications in health and diseases","volume":"5","author":"Rahmouni","year":"2005","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.survophthal.2006.10.017_bib141","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","article-title":"Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization","volume":"44","author":"Rakic","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib142","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.102185799","article-title":"Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis","volume":"99","author":"Ritter","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib143","series-title":"Ocular Angiogenesis","first-page":"279","article-title":"Integrins in Ocular Angiogenesis","author":"Ritter","year":"2006"},{"key":"10.1016\/j.survophthal.2006.10.017_bib144","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/exer.2001.1132","article-title":"Safety and pharmacokinetics of intravitreal 2-methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization","volume":"74","author":"Robinson","year":"2002","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib145","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3928\/1542-8877-20050701-15","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2006.10.017_bib146","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3928\/1542-8877-20050701-14","article-title":"Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration","volume":"36","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.survophthal.2006.10.017_bib147","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ophtha.2005.01.043","article-title":"Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration","volume":"112","author":"Rosenfeld","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib148","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jgm.586","article-title":"Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer","volume":"6","author":"Rota","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib149","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0014-4835(03)00127-1","article-title":"Involvement of fibroblast growth factors in choroidal angiogenesis and retinal vascularization","volume":"77","author":"Rousseau","year":"2003","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib150","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1387\/ijdb.041895ms","article-title":"Development and pathology of the hyaloid, choroidal and retinal vasculature","volume":"48","author":"Saint-Geniez","year":"2004","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib151","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","article-title":"VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib152","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/sj.gt.3301320","article-title":"Blockade of TGF-beta by in vivo gene transfer of a soluble TGF-beta type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis","volume":"7","author":"Sakamoto","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.survophthal.2006.10.017_bib153","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1126\/science.2422759","article-title":"Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor","volume":"232","author":"Schreiber","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib154","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1167\/iovs.03-0342","article-title":"The role of adult bone marrow-derived stem cells in choroidal neovascularization","volume":"44","author":"Sengupta","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(03)00551-8","article-title":"TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism","volume":"114","author":"Seo","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib156","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/S0002-9440(10)65430-2","article-title":"Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor","volume":"154","author":"Seo","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib157","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/00006982-200603000-00002","article-title":"Electrophysiologic and retinal penetration studies following intravitreal injection of bevacizumab (Avastin)","volume":"26","author":"Shahar","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2006.10.017_bib158","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00270416","article-title":"Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy","volume":"30","author":"Sharp","year":"1987","journal-title":"Diabetologia"},{"key":"10.1016\/j.survophthal.2006.10.017_bib159","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.gt.3302641","article-title":"Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1","volume":"13","author":"Shen","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.survophthal.2006.10.017_bib160","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.1095505","article-title":"Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells","volume":"304","author":"Shen","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib161","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.exer.2005.04.005","article-title":"Suppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatin","volume":"81","author":"Sheu","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib162","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1126\/science.6199844","article-title":"Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor","volume":"223","author":"Shing","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib163","first-page":"119","article-title":"Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo","volume":"98","author":"Silletti","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib164","first-page":"2784","article-title":"Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature","volume":"58","author":"Sills","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(01)00015-5","article-title":"MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology","volume":"21","author":"Sivak","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib166","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1126\/science.276.5319.1706","article-title":"Essential role of growth hormone in ischemia-induced retinal neovascularization","volume":"276","author":"Smith","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.survophthal.2006.10.017_bib167","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/70963","article-title":"Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor","volume":"5","author":"Smith","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib168","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2006.10.017_bib169","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2006.10.017_bib170","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ophtha.2004.08.012","article-title":"Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.017_bib171","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2174\/1381612033454621","article-title":"Plasminogen activator inhibitor-1 in tumor growth, angiogenesis and vascular remodeling","volume":"9","author":"Stefansson","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.survophthal.2006.10.017_bib172","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJMoa040833","article-title":"Missense variations in the fibulin 5 gene and age-related macular degeneration","volume":"351","author":"Stone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib173","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","article-title":"CXC chemokines in angiogenesis of cancer","volume":"14","author":"Strieter","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib174","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.cytogfr.2005.04.007","article-title":"CXC chemokines in angiogenesis","volume":"16","author":"Strieter","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.survophthal.2006.10.017_bib175","doi-asserted-by":"crossref","first-page":"27348","DOI":"10.1074\/jbc.270.45.27348","article-title":"The functional role of the ELR motif in CXC chemokine-mediated angiogenesis","volume":"270","author":"Strieter","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib176","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s000180050210","article-title":"The angiogenins","volume":"54","author":"Strydom","year":"1998","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib177","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0070-2153(04)64009-9","article-title":"Integrins and angiogenesis","volume":"64","author":"Stupack","year":"2004","journal-title":"Curr Top Dev Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib178","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0092-8674(00)81813-9","article-title":"Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis","volume":"87","author":"Suri","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.survophthal.2006.10.017_bib179","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0002-9440(10)65281-9","article-title":"Expression of thrombospondin-1 in ischemia-induced retinal neovascularization","volume":"154","author":"Suzuma","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib180","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1096\/fj.02-0824fje","article-title":"Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment","volume":"17","author":"Takahashi","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.survophthal.2006.10.017_bib181","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0002-9394(00)00772-8","article-title":"Inhibition of experimental choroidal neovascularization by overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells","volume":"130","author":"Takahashi","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib182","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2004.03.003","article-title":"PDGF signaling in cells and mice","volume":"15","author":"Tallquist","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.survophthal.2006.10.017_bib183","first-page":"2567","article-title":"Potential of the aminosterol, squalamine in combination therapy in the rat 13,762 mammary carcinoma and the murine Lewis lung carcinoma","volume":"18","author":"Teicher","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib184","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1083\/jcb.122.2.497","article-title":"Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity","volume":"122","author":"Tolsma","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib185","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/13543784.12.6.933","article-title":"Angiopoietins in angiogenesis and beyond","volume":"12","author":"Tsigkos","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.survophthal.2006.10.017_bib186","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1074\/jbc.C400431200","article-title":"VE-cadherin links tRNA synthetase cytokine to anti-angiogenic function","volume":"280","author":"Tzima","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib187","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ijc.21479","article-title":"Epidermal growth factor receptor and angiogenesis: Opportunities for combined anticancer strategies","volume":"117","author":"van Cruijsen","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.survophthal.2006.10.017_bib188","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1009296700991","article-title":"Angiogenesis induced by tumor necrosis factor-agr; is mediated by alpha4 integrins","volume":"2","author":"Vanderslice","year":"1998","journal-title":"Angiogenesis"},{"key":"10.1016\/j.survophthal.2006.10.017_bib189","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/jnci\/87.8.581","article-title":"Inhibition of angiogenesis in vivo by interleukin 12","volume":"87","author":"Voest","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.survophthal.2006.10.017_bib190","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1084\/jem.188.6.1039","article-title":"Inhibition of angiogenesis by interleukin 4","volume":"188","author":"Volpert","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib191","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcb.20480","article-title":"Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated","volume":"96","author":"Wahl","year":"2005","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.survophthal.2006.10.017_bib192","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1073\/pnas.012602099","article-title":"A human aminoacyl-tRNA synthetase as a regulator of angiogenesis","volume":"99","author":"Wakasugi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.survophthal.2006.10.017_bib193","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tcm.2005.11.008","article-title":"Angiogenesis: the VE-cadherin switch","volume":"16","author":"Wallez","year":"2006","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.survophthal.2006.10.017_bib194","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.survophthal.2006.10.017_bib195","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)63214-2","article-title":"Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy","volume":"164","author":"Wilkinson-Berka","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","article-title":"Vascular endothelial growth factors and angiogenesis in eye disease","volume":"22","author":"Witmer","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2006.10.017_bib197","first-page":"28","article-title":"Inhibition of corneal angiogenesis by local application of vasostatin","volume":"11","author":"Wu","year":"2005","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2006.10.017_bib198","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1083\/jcb.200103111","article-title":"Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo","volume":"154","author":"Xu","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2006.10.017_bib199","first-page":"842","article-title":"Targeting of interferon to choroidal neovascularization by use of dextran and metal coordination","volume":"43","author":"Yasukawa","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.017_bib200","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.bbrc.2006.03.006","article-title":"Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch","volume":"343","author":"Zhang","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.survophthal.2006.10.017_bib201","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood-2003-08-2920","article-title":"Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells","volume":"103","author":"Zhang","year":"2004","journal-title":"Blood"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625706002116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625706002116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:31:34Z","timestamp":1758540694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625706002116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":201,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0039625706002116"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2006.10.017","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular Neovascularization: Basic Mechanisms and Therapeutic Advances","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2006.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}